Nature Cancer
@NatureCancer
Nature Cancer is a journal dedicated to publishing the latest advances across all areas of cancer research.
ID:1084943471436316673
http://nature.com/natcancer 14-01-2019 22:40:55
2,1K Tweets
33,0K Followers
303 Following
Follow People
Anirban Maitra
Pancreatic cancer researcher and GI pathologist. Striving to improve the lives of patients with cancer. 🇺🇸 🇮🇳
Vivek Subbiah, MD
Chief, Early-Phase Drug Development|@SarahCannonDocs #Oncologist, #Phase1trials, #PrecisionMedicine. Tweets=My own.
FrezzaLab
We are a group of metabolism-lovers, focused on mitochondrial metabolism. Tweets are from Christian. https://t.co/EbWsJo6DnZ
Johanna Joyce
Professor at Univ. Lausanne 🇨🇭 @Joycelab @unil @ludwig_cancer | Cancer researcher - tumor microenvironment & immunology | Mentor, Teacher, Advocate, Mum
NatureRevClinOncol
The latest clinical diagnostic, treatment & personalized medicine advances & more from Nature Reviews Clinical Oncology, a reviews journal. Tweets by the eds.
⭐️NEW REVIEW ARTICLE Nature Cancer
“Cycling back to folate metabolism in cancer”
Read it here:
👉doi.org/10.1038/s43018…
#cancermetabolism
✨NEW CONTENT Nature Cancer “Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial” #clinicaltrial
nature.com/articles/s4301…
💫ONLINE NOW Nature Cancer “Single-cell multiomic dissection of response and resistance to chimeric antigen receptor T cells against BCMA in relapsed multiple myeloma” #immunotherapy
nature.com/articles/s4301…
✨ONLINE NOW Nature Cancer “An oncolytic virus delivering tumor-irrelevant bystander T cell epitopes induces anti-tumor immunity and potentiates cancer immunotherapy” #immunotherapy
nature.com/articles/s4301…
✨ONLINE NOW Nature Cancer “Threonine fuels glioblastoma through YRDC-mediated codon-biased translational reprogramming” #Glioblastoma
Read it here 👇
nature.com/articles/s4301…
💫DON’T MISS Nature Cancer “Tissue-specific thresholds of mutation burden associated with anti-PD-1/L1 therapy benefit and prognosis in microsatellite-stable cancers” #immunotherapy
Read it here 👇
nature.com/articles/s4301…
⭐️NEW CONTENT Nature Cancer - “Associations of seven measures of biological age acceleration with frailty and all-cause mortality among adult survivors of childhood cancer in the St. Jude Lifetime Cohort”
Read it here👇
nature.com/articles/s4301…
📢Come join our Nature Cancer editorial team!
We're hiring an Associate/Senior Editor in our Shanghai, Beijing, New York or Philadelphia offices🌎.
Application deadline April 28th🗓️
Please spread the word‼️
Find details here:
nature.com/naturecareers/…
✨NEW REVIEW ARTICLE Nature Cancer “The pleiotropic functions of reactive oxygen species in cancer”
Find it here👇
nature.com/articles/s4301…
⭐️ONLINE NOW Nature Cancer - 'Trans-Atlantic twists and turns' - a Turning Point Article describing career-defining moments by Johanna Joyce
nature.com/articles/s4301…
Explore the forefront of cancer immunotherapy at our upcoming conference in Boston with Dana-Farber. Leaders in the field will present cutting-edge research, focusing on translating fundamental knowledge to the clinic and back. Learn more: go.nature.com/CancerImm
✨ONLINE NOW Nature Cancer “Synthetic dual co-stimulation increases the potency of HIT and TCR-targeted cell therapies” #CARTcells
nature.com/articles/s4301…
✨ONLINE NOW Nature Cancer “Synthetic dual co-stimulation increases the potency of HIT and TCR-targeted cell therapies” #CARTcells
nature.com/articles/s4301…